Scias quiescere potes ex officina nostra emere N(2-Amino-4,6-dichloro-5-pyrimidinyl)formamide CAS 171887-03-9. CAS 171887-03-9 media pars momenti est abacavirorum. Abacavir medicamentum novum anti-AIDS, quod novum carbocycli2 -deoxyguanosinum nucleoside pharmacum. Bioavailability oralis eius alta est, et facile est in systema chemical libri CNS penetrare. Medicamentum est nucleoside e reverso transcriptase praeparatio ex Glaxo Wilcome approbata ad ingressum mercatus per processum approbationis velocitatis FDA mense Decembri 1998. In Aprili 2004, medicamentum a FDA probatum est pro infectione anti-HIV.
Crede Chemicum principem Sinarum N(2-Amino-4,6-dichloro-5-pyrimidinyl)formamideum CAS 171887-03-9 fabricam, supplementum et exportatorem. Shandong Credite
|
Product Name |
N-(2-Amino-4,6-dichloro-5-pyrimidinyl)formamide |
||
|
Formulae |
C5H4Cl2N4O |
M. Pondus |
207.02 |
|
CAS NO. |
171887-03-9 |
quantitas |
500KG |
|
Items |
Specification |
Proventus |
|
Aspectus |
Pulvis |
Conforms |
|
Assay |
⥠99% |
Conforms |
|
Liquescens punctum |
|
Conforms |
|
Densitas |
1.742±0.06 g/cm3(Praedicta) |
Conforms |
|
CONCLUSIO |
Effectus conformis vexillum |
|
Synonym: sulfinylbis (methanum); DMSO;DIMETHYL SULFOXIDE;DIMETHYL SULPHOXIDE;DIMETHYLIS sulfoxidum;FEMA 3875;
CAS;
Formulae hypotheticae:
Pondus hypotheticum:
EINECS: 425-650-6
Ferveret:
Densitas:
Repono conditiones:
Vita fasciae: 2 years
N-(2-Amino-4,6-dichloro-5-pyrimidinyl)formamide CAS 171887-03-9 tanquam medium pharmaceuticum. Intermedium magni ponderis est Abacavir. Abacavir medicamentum novum anti-AIDS, quod novum carbocyclicum 2 '-deoxyguanosinum nucleoside pharmacum'. Bioavailability oralis eius alta est et facile in systema nervosum centrale penetratur.
